NIH-funded research NIH-funded research

Addressing heart disease risk with HIV care in Nigeria

Official title: Addressing CVD Multimorbidity in Patients Living with HIV in Nigeria

Funded at New York University School of Medicine · NIH-11541966 · Data updated 2026-11-12

A plan to bring heart-disease prevention and treatment into HIV care for people living with HIV in Nigeria.

More Multimorbidity research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2027
Funding year2026
Award (this year)$123,855
NIH project number3R61HL184905-01S1
Project IDNIH-11541966 on NIH RePORTER

Who could benefit from this research

Could help

PLWH in Nigeria who also have or are at risk for hypertension and diabetes and receive care at participating primary healthcare centers.

Less likely to help

Patients outside Lagos or those not receiving HIV care at participating clinics may not directly benefit.

What this research studies

This project tests a patient-centered approach called HEARTS to manage diabetes and high blood pressure within HIV clinics in primary care settings in Lagos, Nigeria. It builds on a proven model that reduced systolic blood pressure by 15 mmHg in a previous study, and aims to see if it can also control diabetes and hypertension alongside HIV care. Researchers will use a Chronic Care Model to implement and evaluate how well this integrated care works for patients with multiple conditions. The study is conducted through primary care clinics and involves real patients whose care could improve with coordinated management of HIV, diabetes, and hypertension.

Why it matters

Potential benefit: If successful, patients could experience better control of blood pressure and diabetes within their HIV care, potentially reducing cardiovascular risk.

How similar studies have gone: A prior NIH-funded trial showed significant blood pressure reduction by integrating HTN management into HIV care, supporting this approach's potential.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Ogedegbe, Olugbenga G. — New York University School of Medicine
  • Study coordinator: Ogedegbe, Olugbenga G.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.